Lexicon Pharmaceuticals, Inc.
LXRX
Revenue
1.62M
▲524.00k▲47.94%
3 Months ChangeAssets
373.36M
▼-43.86M▼-10.51%
3 Months ChangeLiabilities
133.38M
▲5.02M▲3.91%
3 Months ChangeFree Cash Flow
-55.13M
▼-23.27M▼-73.03%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0001062822-24-000054
2024-09-16
Form 8-K
ID: 0001062822-24-000051
2024-08-02
Form 10-Q
ID: 0001062822-24-000046
2024-08-01
Form 8-K
ID: 0001062822-24-000043
2024-07-08
Form 8-K
ID: 0001062822-24-000036
2024-07-01
Form 8-K
ID: 0001062822-24-000032
2024-05-10
Form 8-K
ID: 0001062822-24-000029
2024-05-02
Form 10-Q
ID: 0001062822-24-000024
2024-05-02
Form 8-K
ID: 0001062822-24-000023
2024-04-29
Form 8-K
ID: 0001062822-24-000020